#Wirecard WDI GR short int is $2.88BN; 29.83MM shs shorted; 25.97% of float; 4.00% borrow fee. Shs shorted up +3.34MM shs,+12.62%,over last 30 days as price fell -12.7% & up 3.91MM shs,+15.1%,last week.Shorts up +$604MM in 2020 mark-to-market profits;+$47MM on today's -1.63% move pic.twitter.com/p9VEp9EEl2
— Ihor Dusaniwsky (@ihors3) May 5, 2020
Release: Groupon, Inc. Class Action Alert Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Groupon, Inc.
Release5 May 2020
Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Groupon, Inc. (“Groupon” or the “Company”) (NASDAQ: GRPN) in the United States District Court for the Northern District of Illinois on behalf of those who purchased or acquired the securities of Groupon between November 4, 2019 and February 18, 2020, inclusive (the “Class Period”).
Article: If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You’d Have Made 91%
Article - Media, PublicationsIf You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You’d Have Made 91%
Simply Wall St, 05 May 2020
In late January 2021, GameStop experienced a once-in-a-decade squeeze that has captivated the world’s attention. It was a premeditated and programmatic exercise, orchestrated by coordinated stock and option buying across the retail and professional community, resulting in large institutional entities losing billions of dollars. Investment houses with significant short positions did not expect a stock with GameStop’s fundamental profile to increase +2,500% in price over less than three weeks; therefore, they did not have the controls in place to handle the incredible levels of stock and call option purchases. The frenzy drew comments from the White House, provoked a social media crackdown, caused brokerage units to restrict trading, and has led to a Congressional hearing on GameStop on Thursday, February 18th.
Continue reading “Article: If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You’d Have Made 91%”
Article: Wirecard sues Financial Times over investigative reports
Article - MediaWirecard sues Financial Times over investigative reports
Straits Times (Singapore), 29 March 2019
Wirecard has filed a suit at the Munich regional court against both the FT and its reporter, Dan McCrum, seeking a ruling on the merits of its case. If successful, the company would then press for monetary redress.
Comment: Use the tag cloud to find other articles about Dan McCrum, suspected to be in collusion with naked short sellers.
Article: Sell Microvision: Nothing Left To Be Optimistic About
Article - MediaSell Microvision: Nothing Left To Be Optimistic About
SeekingAlpha.com, 29 January 2020
Summary: Unsustained purchase orders have crushed sales.
Comment: If lying were illegal these people would be in jail. Known basher in league with naked short sellers.
Web: MicroVision (MVIS) Being Fucked Today
Web| May 05, 2020 | 1.6900 | 1.7400 | 1.4300 | 1.6000 | 1.6000 | 52,496,924 |
| May 04, 2020 | 0.8900 | 1.1400 | 0.7900 | 1.1000 | 1.1000 | 204,529,700 |
Comment: MVIS look at volume last few days The Volume is crazy last 5 days. NOT 1 FTD?
Web: Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
Article - Media| May 05, 2020 | 0.6300 | 0.7300 | 0.5700 | 0.5800 | 0.5800 | 29,745,000 |
| May 04, 2020 | 0.5200 | 0.5300 | 0.5000 | 0.5200 | 0.5200 | 1,597,600 |
Comment: NOW LOOK AT THE NEWS Just who would sell all that stock on that GREAT news (only a naked short seller TRAPPED).
#UNRIG Video (38:19) Naked Short Selling Interview #2 – Robert Shapiro Talks Wall St Corruption
VideoAt his request on 26 May 2020 this video has been removed from the web site. Under no circumstances will Dr. Shapiro’s published works be removed. See those here: Shapiro @ SNSS
Article: Aristides Capital LLC closes position in NLTX / Neoleukin Therapeutics, Inc
Article - Media, PublicationsAristides Capital LLC closes position in NLTX / Neoleukin Therapeutics, Inc
Fintel, 15 May 2020
Aristides Capital LLC has filed a 13F-HR form disclosing ownership of 0 shares of Neoleukin Therapeutics, Inc. (US:NLTX) with total holdings valued at $0 USD as of 2020-03-31. Aristides Capital LLC had filed a previous 13F-HR on 2020-02-13 disclosing 13,900 shares of Neoleukin Therapeutics, Inc. at a value of $171,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter. Other investors with closed positions include Visium Asset Management, LP, Great Point Partners Llc, Perceptive Advisors Llc, Acuta Capital Partners, Llc, and Nomura Asset Management Co Ltd.
Continue reading “Article: Aristides Capital LLC closes position in NLTX / Neoleukin Therapeutics, Inc”
Web: Why is Naked Short Selling Both Illegal and Common Practice?
WebWhy is Naked Short Selling Both Illegal and Common Practice?
First American Stock Transfer, undated
The Depository Trust & Clearing Corporation or DTCC (the final depository where all U.S. trades are settled and cleared) cannot settle fraudulent trades. According to the DTCC website, “We don’t have any power or legal authority to regulate or stop short-selling, naked or otherwise.”
While DTCC may not have the authority to regulate any short selling, it could create computer programs that would track share holdings to determine if they are real shares or simply entitled. Some believe that the DTCC chooses not to monitor these transactions more closely, because they make money on the interest and the loaning of these shares.
Tweet: Susan Trimbath PhD on Impossible Buyins, Seller Must Pay Cash to Buyer
Tweet"There will be occasions where, often for reasons of reduced liquidity, a buy-in is impossible to execute. In this situation, the seller will be required to pay a cash compensation to the buyer."https://t.co/R237awFnbA
— Susanne Trimbath PhD (@SusanneTrimbath) May 4, 2020
See Also:
Article: Wall Street Recommends Buying These 2 Falling Knives
Article - MediaWall Street Recommends Buying These 2 Falling Knives
Alberto Abaterusso
Guru Focus, 13 April 2020
Sell-side analysts on Wall Street recommend to buy shares of Stemline Therapeutics Inc (NASDAQ:STML) and KalVista Pharmaceuticals Inc (NASDAQ:KALV), even though their share prices have lost more than 59% over the past 52 weeks through April 10. Due to such tumbles, these stocks are known as falling knives.
Release: INVESTOR ALERT Law Offices of Howard G. Smith Continues Investigation of InnerWorkings, Inc. (INWK) on Behalf of Investors
Release4 May 2020
Law Offices of Howard G. Smith continues its investigation on behalf InnerWorkings, Inc. (“InnerWorkings” or “the Company”) ( INWK) investors concerning the Company and its officers’ possible violations of federal securities laws.
Release: Canaan Inc. Investor Alert Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action has been filed in the United States District Court for the District of Oregon against Canaan Inc.
Release4 May 2020
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the District of Oregon on behalf of purchasers of the American Depositary Receipts (“ADR’s”) of Canaan Inc. (NASDAQ: CAN) pursuant and/or traceable to the Company’s initial public offering (“IPO”) commenced on or about November 20, 2019.
#UNRIG Video (39:06) Naked Short Selling Interview #1 – Wes Christian, pioneering attorney on the big picture
Video
